...
首页> 外文期刊>Biochemistry >Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists.
【24h】

Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists.

机译:大肠杆菌热不稳定肠毒素和霍乱毒素的神经节苷脂GM1结合位点的基于结构的探索,以发现受体拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Ganglioside GM1 is the natural receptor for cholera toxin (CT) and heat-labile enterotoxin (LT), which are the causative agents of cholera and traveler's diarrhea, respectively. This observation suggests that small molecules interfering with this recognition process may prevent entry of the toxins into intestinal cells, thereby averting their devastating effects. Here, the terminal sugar of ganglioside GM1, galactose, was chosen as a lead in designing such receptor antagonists. Guided by the experimentally determined binding mode of galactose, we selected a "substructure" for searching the Available Chemicals Database, which led to the purchase of 35 galactose derivatives. Initial screening of these compounds in an LT ELISA revealed that 22 of them have a higher affinity for LT than galactose itself. A structurally diverse subset of these galactose derivatives was selected for determination of IC50 values in the LT ELISA and IC50 values in a CT assay, as well as for the determination of Kd's using the intrinsic fluorescence of LT. The best receptor antagonist found in this study was m-nitrophenyl alpha-galactoside with an IC50 of 0.6 (2) mM in the LT ELISA and 0.72 (4) mM in the CT assay, 100-fold lower than both IC50 values of galactose. Careful analysis of our binding data and comparison with crystal structures led to the derivation of correlations between the structure and affinity of the galactose derivatives. These characteristics will be used in the design of a second round of LT and CT receptor antagonists.
机译:神经节苷脂GM1是霍乱毒素(CT)和不耐热肠毒素(LT)的天然受体,它们分别是霍乱和旅行者腹泻的病因。该观察结果表明,干扰此识别过程的小分子可能会阻止毒素进入肠道细胞,从而避免其破坏作用。在这里,神经节苷脂GM1的末端糖半乳糖被选为设计此类受体拮抗剂的先导。在实验确定的半乳糖结合模式的指导下,我们选择了一个“子结构”来搜索“可用化学品”数据库,从而购买了35个半乳糖衍生物。在LT ELISA中对这些化合物的初步筛选显示,它们中的22种对LT的亲和力高于半乳糖本身。选择这些半乳糖衍生物在结构上的不同子集,以确定LT ELISA中的IC50值和CT分析中的IC50值,以及使用LT的固有荧光确定Kd。这项研究中发现的最佳受体拮抗剂是间硝基苯基α-半乳糖苷,LT ELISA的IC50为0.6(2)mM,CT分析的IC50为0.72(4)mM,比半乳糖的两个IC50值低100倍。仔细分析我们的结合数据并与晶体结构进行比较,得出了半乳糖衍生物的结构和亲和力之间的相关性。这些特征将用于第二轮LT和CT受体拮抗剂的设计中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号